Table 1 Characteristics of patients at baseline
A. Socio-demographic variables expressed as mean (SD) | ||||||||
|---|---|---|---|---|---|---|---|---|
N | Minimum | Maximum | Mean | Standard deviation | ||||
AGE (years) | 119 | 60 | 100 | 84 | 7.15 | |||
WEIGHT (kg) | 103 | 40 | 120 | 65 | 13.02 | |||
SIZE (cm) | 72 | 140 | 181 | 160 | 7.92 | |||
BMI (kg/m 2 ) | 71 | 12 | 31 | 20 | 3.63 | |||
B. Socio-demographic variables expressed in percentage (%) | ||||||||
Frequency | Percentage | |||||||
VALID | Man | 25 | 21 | |||||
Woman | 95 | 80 | ||||||
Total | 120 | 100 | ||||||
C. Variables related to the main objective | ||||||||
BUPI (N =60) | LEVO (N =60) | |||||||
Mean | Standard deviation | Minimum | Maximum | Mean | Standard deviation | Minimum | Maximum | |
AGE (years) | 83 | 7.24 | 60 | 96 | 85 | 6.92 | 66 | 100 |
WEIGHT (kg) | 66 | 14.78 | 44 | 120 | 64 | 11.32 | 40 | 90 |
SIZE (cm) | 159 | 7.83 | 140 | 181 | 160 | 8.08 | 140 | 175 |
BMI (kg/m 2 ) | 20 | 3.57 | 14 | 27 | 20 | 3.73 | 12 | 31 |
SBP (mmHg) | 143 | 19.50 | 110 | 190 | 156 | 28.33 | 100 | 230 |
DBP (mmHg) | 82 | 13.74 | 60 | 120 | 79 | 20.04 | 50 | 175 |
HR ((bpm) | 85 | 17.84 | 60 | 150 | 89 | 21.27 | 50 | 170 |
Hb (g/dl) | 12 | 1.62 | 8 | 16 | 12 | 1.61 | 8 | 18 |
SpO 2 (%) | 96 | 3.66 | 85 | 100 | 95 | 2.75 | 88 | 99 |
D. Clinical variables | ||||||||
BUPI (N =60) | LEVO (N =60) | |||||||
N | % | N | % | |||||
GENDER | Man | 11 | 18% | 14 | 23% | |||
Woman | 49 | 82% | 46 | 77% | ||||
BASIC PATHOLOGY | RESPIRATORY | 13 | 22% | 8 | 13% | |||
VASCULAR | 44 | 73% | 39 | 65% | ||||
NEUROLOGICAL | 23 | 38% | 24 | 40% | ||||
CARDIAC | 21 | 35% | 25 | 42% | ||||
HEPATIC/RENAL | 7 | 12% | 10 | 17% | ||||
ENDOCRINE/METABOLIC | 31 | 52% | 30 | 50% | ||||
HISTORY OF ANTI-PLATELET OR ANTICOAGULANT AGENT | 25 | 42% | 26 | 43% | ||||
USE PRIOR TO SURGERY: PREMEDICATION | 40 | 67% | 51 | 85% | ||||
TYPE OF HIP FRACTURE | Head neck fracture | 0 | 0% | 0 | 0% | |||
Subcapital fracture | 21 | 35% | 15 | 25% | ||||
Transcervical fracture | 0 | 0% | 2 | 3% | ||||
Basicervical fracture | 6 | 10% | 8 | 13% | ||||
Pertrochanteric fracture | 28 | 47% | 30 | 50% | ||||
Subtrochanteric fracture | 4 | 7% | 5 | 8% | ||||
DURING SURGERY | OSTEOSYNTHESIS IMPLANT TYPE | Osteosynthesis (OS) | 4 | 7% | 2 | 3% | ||
Partial hip prosthesis (PHP) | 17 | 28% | 17 | 28% | ||||
Total hip prosthesis (THP) | 4 | 7% | 2 | 3% | ||||
Arthroplasty (ARP) | 0 | 0% | 0 | 0% | ||||
Dynamic Hip System plates (DHS) | 28 | 47% | 25 | 42% | ||||
GAMMA plates (GAMMA) | 8 | 13% | 8 | 13% | ||||
Condylar Nail-Plate s (DCS) | 0 | 0% | 0 | 0% | ||||
Others (Oth) | 0 | 0% | 5 | 8% | ||||
SPINAL LEVEL | L2-L3 | 13 | 22% | 10 | 17% | |||
L3-L4 | 35 | 58% | 31 | 52% | ||||
L4-L5 | 12 | 20% | 19 | 32% | ||||
ANESTHESIC VOLUME | 1 ml | 4 | 7% | 18 | 30% | |||
1.2 ml | 10 | 17% | 36 | 60% | ||||
1.3-1.5 ml | 32 | 53% | 5 | 8% | ||||
>1.5 ml | 14 | 23% | 1 | 2% | ||||
DOSE OF FENTANYL | 5 | 1 | 1.7% | 0 | 0% | |||
10 | 52 | 87% | 56 | 93% | ||||
15 | 3 | 5% | 0 | 0% | ||||